Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Nagel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Investigative Dermatology|January 17, 2009
B-cell-directed therapy for inflammatory skin diseasesAngela Nagel, Michael Hertl, Rüdiger Eming
International Archives of Allergy and Immunology|April 8, 2006
Type I regulatory T cells in autoimmunity and inflammatory diseasesChristian Veldman, Angela Nagel, Michael Hertl
Plos One|October 21, 2014
CD3-positive B cells: a storage-dependent phenomenonAngela Nagel, Christian Möbs, Hartmann Raifer, et al.
The Journal of Investigative Dermatology|June 20, 2008
Rituximab exerts a dual effect in pemphigus vulgarisRüdiger Eming, Angela Nagel, Sonja Wolff-Franke, et al.
The Journal of Investigative Dermatology|March 14, 2009
Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgarisAngela Nagel, Eva Podstawa, Markus Eickmann, et al.
Clinical Immunology (Orlando, Fla.)|December 18, 2009
Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3Angela Nagel, Angelika Lang, Dorothee Engel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 5, 2019
A community-wide quality improvement initiative to improve hypertension control and reduce disparitiesRobert J Fortuna, Thomas A Rocco, Jeffrey Freeman, et al.
Plos One|January 10, 2020
Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assayAngela Nagel, Emmanouela Dimitrakopoulou, Norbert Teig, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Investigative Dermatology|January 17, 2009
B-cell-directed therapy for inflammatory skin diseasesAngela Nagel, Michael Hertl, Rüdiger Eming
International Archives of Allergy and Immunology|April 8, 2006
Type I regulatory T cells in autoimmunity and inflammatory diseasesChristian Veldman, Angela Nagel, Michael Hertl
Plos One|October 21, 2014
CD3-positive B cells: a storage-dependent phenomenonAngela Nagel, Christian Möbs, Hartmann Raifer, et al.
The Journal of Investigative Dermatology|June 20, 2008
Rituximab exerts a dual effect in pemphigus vulgarisRüdiger Eming, Angela Nagel, Sonja Wolff-Franke, et al.
The Journal of Investigative Dermatology|March 14, 2009
Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgarisAngela Nagel, Eva Podstawa, Markus Eickmann, et al.
Clinical Immunology (Orlando, Fla.)|December 18, 2009
Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3Angela Nagel, Angelika Lang, Dorothee Engel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 5, 2019
A community-wide quality improvement initiative to improve hypertension control and reduce disparitiesRobert J Fortuna, Thomas A Rocco, Jeffrey Freeman, et al.
Plos One|January 10, 2020
Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assayAngela Nagel, Emmanouela Dimitrakopoulou, Norbert Teig, et al.
Pageof 1